• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • LinkedIn
  • YouTube
  • Instagram
  • X
  • Contact Us
  • Clinical Trials
  • Careers
  • Investors
Insmed Insmed

Insmed

  • Company

    Company

    Get to know Insmed, see what drives us, and learn how weโ€™re building a company where people come first.

    Learn about our company

    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients

    Patients

    See how we collaborate with patients to shape every step of our shared journey.

    Learn about our
    commitment to patients

    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access

    Current Clinical Trials

    Learn more about our clinical trials or find a relevant trial near you.

    See if you may qualify

  • Science

    Science

    Discover the innovative science that fuels our commitment to delivering breakthroughs.

    Learn about our science

    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies

    Therapies

    Learn about our therapies

    • ARIKAYCEยฎ
    • BRINSUPRIยฎ
  • Responsibility

    Responsibility

    See how weโ€™re continuing to advance science sustainably and ethically.

    Learn about our
    commitment to responsibility

    • Patients we serve
    • Innovation we deliver
    • People we empower
    • Communities we strengthen
    • Planet we protect
    • Governance we uphold
      • Global Healthcare Compliance
      • Policies & Disclosures

    Responsibility Report

    Our Responsibility Report reflects the culture and purpose we live by every day. We are committed to reporting annually on our progress and commitments.

    Learn more

  • Company
    • Company
    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships
  • Patients
    • Patients
    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access
  • Science
    • Science
    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies
    • Therapies
    • ARIKAYCEยฎ
      BRINSUPRIยฎ
  • Responsibility
    • Responsibility
    • Patients we serve
    • Innovation we deliver
    • People we empower
    • Communities we strengthen
    • Planet we protect
    • Governance we uphold
    • Global Healthcare Compliance
    • Policies & Disclosures
  • Investors
  • Press Releases
  • Events & Presentations
  • Financials & Filings
    • Earnings Results
    • Annual Reports
    • SEC Filings
  • Corporate Governance
  • Responsibility Reports
  • Resources
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts

Press Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • May 13, 2015
    Insmed Announces Upcoming Data Presentations at the American Thoracic Society 2015 International Meeting

    Read more

  • May 11, 2015
    Insmed to Participate at the UBS Global Healthcare Conference

    Read more

  • May 7, 2015
    Insmed Reports First Quarter 2015 Financial Results

    Read more

  • Apr 6, 2015
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares

    Read more

  • Mar 31, 2015
    Insmed Announces Pricing of Public Offering of Common Stock

    Read more

  • Mar 30, 2015
    Insmed Announces Proposed Public Offering of Common Stock

    Read more

  • Mar 27, 2015
    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Read more

  • Mar 23, 2015
    Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer
    20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases

    Read more

  • Feb 27, 2015
    Insmed Reports 2014 Fourth Quarter and Full Year Financial Results
    Marketing Authorization Application for ARIKAYCETM Validated by the European Medicines Agency

    Read more

  • Feb 24, 2015
    Insmed to Participate at Cowen & Company's 35th Annual Health Care Conference

    Read more

Show 5102550100 per page
  • «
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 78
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Sign Up

Investor Presentation

View the latest Insmed Investor Presentation

Download

Footer

Insmed

LinkedIn YouTube Instagram X

Terms of Use Privacy Policy California Notice at Collection U.S. Consumer Health Data Privacy Policy Your Privacy Choices

ยฉ 2026 Insmed Incorporated. All Rights Reserved.

You are now leaving Insmed's website.

Insmed does not control, review, or endorse third-party websites, and you agree that Insmed is not responsible for the content of the website you are about to enter.